These results elucidate unknown beneficial effects of the p53/MDMX axis in adipose tissue remodeling, and revealed a surprising role of MDMX inhibition in anti-obesity effects beyond, commonly expected, tumor suppression. This evidence concerns the gene MDM4 and obesity due to melanocortin 4 receptor deficiency.